Cardiovascular Disease Diagnostics: A Global Strategic Business Report
San Jose, CA (PRWEB) March 11, 2008
Rising costs of materials and growing complexity of procedures characterize the field of cardiology today. Cardiovascular disease (CVD) continues to remain the leading cause behind global mortality, accounting for a whopping 17 million deaths per annum. An estimated 30 million people get afflicted from cardiovascular diseases each year. Emerging markets world over, provide substantial market growth for stress testing systems and diagnostics. United States represents the largest market in the worldwide cardiovascular disease diagnostics market, estimated at $2.9 billion in 2007, as stated by Global Industry Analysts, Inc. Europe represents the second largest market, followed by Japan. With the introduction of improved diagnostics, acute and chronic medications and surgical techniques, there has been a significant plunge in total cardiovascular disease mortality over the past few decades.
World cardiovascular in-vivo diagnostics market is estimated US$ 4.1 billion market in 2007. Increasing acceptance of Computed Tomography (CT) and Magnetic Resonance (MR) angiography is expected to modify cath-lab function. Today's cardiologists can contemplate the benefits of emerging 256-slice CT scanner technology. Imaging technologies are non-invasive and provide quicker diagnosis, which not only negates the requirement of invasive diagnostic techniques but also helps in early detection of the disease, especially in case of patients complaining un-diagnosed acute chest pain.
Worldwide cardiac diagnostic medical device market features intense competition triggered by rapid technology advancements and development initiatives. Potential competitors to cardiac diagnostic medical device makers include manufacturers of stress test equipment. Players profiled in the study include Biosite Inc., Cambridge Heart, Inc., Cholestech Corp., EP Medsystems, Roche Diagnostics, and Liposcience, Inc. In the in vivo diagnostics market, leading players comprise major device makers Philips Medical Systems, GE Medical, Siemens Medical Solutions, Hitachi, and Toshiba Medical Systems.
The report titled "Cardiovascular Disease Diagnostics: A Global Strategic Business Report" published by Global Industry Analysts, Inc., categorizes the market into In Vitro Diagnostics and In Vivo Diagnostics. The report uncovers information on leading players and competitive scenario in the cardiac diagnostics market. The report also offers a review of the recent strategic corporate activity, technological breakthroughs, product developments/introductions, and research and development activities of major global and regional market participants. Patient prevalence and incidence for select clinical indications are also provided for strategic insight. Geographic markets analyzed include US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America.
For more details about this research report, please visit http://www.strategyr.com/Cardiovascular_Disease_Diagnostics_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com